Neflamapimod is an oral p38 alpha kinase inhibitor that targets dysfunction and degeneration of acetylcholine-producing ...

A groundbreaking trial for a prostate cancer treatment with fewer side effects has launched in the UK. Backed by the ...

The treatment is suitable for men whose cancer has not spread outside of the prostate gland or has spread to the area just ...

For individuals recovering from neurological conditions such as stroke, traumatic brain injury (TBI), multiple sclerosis, ...

In May 2025, former President Joe Biden's health took a serious turn when his medical team revealed a diagnosis of aggressive ...

Optiscan will carry out a Perth-based imaging study of head and neck cancers, using its novel precision surgical and ...

This article was reviewed by Felix Gussone, MD. Hormones and Fertility in Men: What’s the Connection? Key Takeaways: From ...

To date, there are more than 25 centres globally recruiting patients for the trial. The four UK centres are the Royal Marsden ...

A novel treatment (MA-5) developed by a Tohoku University-led research team will soon undergo phase II clinical trials at ...

To date, there are more than 25 centres globally recruiting patients for the trial. The four UK centres are the Royal Marsden ...

Investing.com -- Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) stock gained 3.7% on Thursday after the company announced it received a new patent in South Korea for its lead compound Aramchol in ...

Frost & Sullivan has released the “2025 White Paper on the Current Landscape and Future Trends of the Mitochondrial Medicine ...